Skip to content

EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors

A Prospective Single-Arm Study of EEG-Based Neural Signal Decoding for Cognitive Function Preservation in Patients Undergoing Brain Tumor Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07699172
Enrollment
10
Registered
2026-07-13
Start date
2026-08-01
Completion date
2028-07-31
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Neoplasm, Brain Tumor Adult, Glioma

Keywords

Electroencephalography, EEG, Neural Signal Decoding, Cognitive Function, Cognitive Preservation, Brain Tumor Surgery

Brief summary

Brain tumors and their surgical treatment may impair cognitive function, affecting patients' quality of life. This prospective single-arm study aims to evaluate the feasibility and clinical utility of an EEG-based neural signal decoding strategy for cognitive function preservation in patients undergoing brain tumor surgery. Participants will undergo standardized neuropsychological assessments together with preoperative, intraoperative, and postoperative electrophysiological recordings. The study will investigate whether EEG-based neural decoding can improve objective cognitive function assessment and support individualized functional preservation during brain tumor surgery.

Detailed description

This is a prospective, single-center, single-arm interventional study designed to investigate an EEG-based neural signal decoding strategy for higher-order cognitive function preservation in patients undergoing brain tumor surgery. Eligible patients with brain tumors scheduled for surgical treatment will be enrolled. Participants will receive standardized neuropsychological assessments before and after surgery. High-density EEG recordings will be acquired during different stages of the perioperative period, including task-based and resting-state paradigms when applicable. Neural signal decoding methods will be used to extract cognitive-related electrophysiological features and evaluate their association with postoperative cognitive outcomes. The primary objective is to evaluate the feasibility of EEG-based neural signal decoding for objective cognitive assessment and functional preservation during brain tumor surgery. Secondary objectives include exploring the relationship between electrophysiological biomarkers and neuropsychological performance, evaluating perioperative cognitive changes, and providing preliminary evidence for individualized cognitive protection strategies in brain tumor patients.

Interventions

PROCEDUREEEG-Based Neural Signal Decoding Strategy

EEG-based neural signal decoding will be performed during the perioperative period to identify cognitive functional networks and assist individualized cognitive function preservation during brain tumor surgery.

Sponsors

Bo Wang
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years to 75 years. * Patients diagnosed with brain glioma and scheduled for surgical treatment. * Conscious and able to understand study procedures. * Able to complete neuropsychological assessments. * Willing to participate and provide written informed consent.

Exclusion criteria

* Severe dysfunction of major organs (heart, lung, liver, or kidney). * Severe psychiatric disorders or cognitive impairment. * Severe language impairment preventing completion of study procedures. * Any other condition judged by the investigator to make participation inappropriate.

Design outcomes

Primary

MeasureTime frameDescription
Mini-Mental State Examination (MMSE) Total ScoreBaseline, postoperative 1 week, postoperative 1 month, and postoperative 3 monthsCognitive function assessed using the Mini-Mental State Examination (MMSE). The total score ranges from 0 to 30, with higher scores indicate better cognitive function.
Montreal Cognitive Assessment (MoCA) Total ScoreBaseline, postoperative 1 week, postoperative 1 month, and postoperative 3 monthsCognitive function assessed using the Montreal Cognitive Assessment (MoCA). The total score ranges from 0 to 30, with higher scores indicate better cognitive function.

Countries

China

Contacts

CONTACTBo Wang
dr.bo.wang@tmu.edu.cn022-59065262

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026